Mental disorders have emerged as the leading cause of disability worldwide, overtaking major illnesses such as cancer and cardiovascular diseases, according to a new global study. The findings have raised serious concerns for India, where...
Dr Reddy’s launches oral semaglutide Obeda in India, expanding treatment options for people living with Type 2 diabetes and marking an important step in making advanced diabetes care more accessible. The Hyderabad-based pharmaceutical compa...
Zydus Lifesciences is preparing for a major international expansion of its semaglutide business, with plans to roll out the drug across more than 20 markets over the next two years. The company is also betting on a sharp scale-up of its biosimil...
Bayer is deepening its India self-care market push as the global pharmaceutical company bets on rising demand for preventive healthcare and over-the-counter wellness products to strengthen its position in one of its fastest-growing markets.
India’s pharmaceutical industry is under pressure as rising costs and an export slump squeeze drugmakers hard, impacting profits and slowing growth. Pharmaceutical companies, which have long benefited from strong overseas demand, are now facin...
India launches Alzheimer’s drug Lormalzi by Eli Lilly, offering hope for early-stage patients with treatment designed to slow cognitive decline.
Karnataka has taken a giant leap in public health governance by launching its drug monitoring portal that automatically blocks the sale of substandard medicines.
An experimental Alzheimer’s drug is advancing despite a trial miss, keeping the Tau Therapy Race alive. The Alzheimer’s drug, designed to target the tau protein linked to cognitive decline, delivered mixed mid-stage results but showed enough...
Swiss pharma giant Roche has introduced Tecentriq SC in India, a faster subcutaneous version of its blockbuster lung cancer treatment that can be administered in just seven minutes.
Patients with Heart Failure and CKD often face serious complications beyond their primary disease. One growing concern is hyperkalaemia, a condition that raises potassium levels in the blood. Doctors now view hyperkalaemia as a recurring clinical...
.jpg)
.jpg)
, CDSCO.jpg)